Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Helius Medical Technologi...

    NASDAQ: HSDT · Real-Time Price · USD
    9.40
    -0.36 (-3.69%)
    At close: Jul 03, 2025, 3:59 PM
    9.30
    -1.06%
    After-hours: Jul 03, 2025, 04:57 PM EDT

    Helius Medical Statistics

    Share Statistics

    Helius Medical has 7.56M shares outstanding. The number of shares has increased by 0.03% in one year.

    Shares Outstanding

    n/a
    		 7.56M

    Shares Change (YoY)

    n/a
    		 0.03%

    Shares Change (QoQ)

    n/a
    		 8%

    Owned by Institutions (%)

    n/a
    		 0.02%

    Shares Floating

    n/a
    		 101.12K

    Failed to Deliver (FTD) Shares

    n/a
    		 1,286

    FTD / Avg. Volume

    n/a
    		 0.93%

    Short Selling Information

    The latest short interest is 2.34M, so 74.02% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.34M

    Short % of Shares Out

    n/a
    		 74.02%

    Short % of Float

    n/a
    		 74.02%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -115.97 and the forward PE ratio is -7.41. Helius Medical's PEG ratio is 1.65.

    PE Ratio

    n/a
    		 -115.97

    Forward PE

    n/a
    		 -7.41

    PS Ratio

    n/a
    		 2618.59

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 1285.8

    P/FCF Ratio

    n/a
    		 -123.27

    PEG Ratio

    n/a
    		 1.65
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Helius Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 1.58

    Quick Ratio

    n/a
    		 1.1

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $24,761.9

    Profits Per Employee

    n/a
    		 $-559,142.86

    Employee Count

    n/a
    		 21

    Asset Turnover

    n/a
    		 0.15

    Inventory Turnover

    n/a
    		 0.56

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -98.67% in the last 52 weeks. The beta is 1.13, so Helius Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.13

    52-Week Price Change

    n/a
    		 -98.67%

    50-Day Moving Average

    n/a
    		 134.45

    200-Day Moving Average

    n/a
    		 343.56

    Relative Strength Index (RSI)

    n/a
    		 21.47

    Average Volume (20 Days)

    n/a
    		 137,541

    Income Statement

    In the last 12 months, Helius Medical had revenue of 520K and earned -11.74M in profits. Earnings per share was -4.33.

    Revenue

    n/a
    		 520K

    Gross Profit

    n/a
    		 -62K

    Operating Income

    n/a
    		 -13.9M

    Net Income

    n/a
    		 -11.74M

    EBITDA

    n/a
    		 -13.8M

    EBIT

    n/a
    		 -13.86M

    Earnings Per Share (EPS)

    n/a
    		 -4.33
    Full Income Statement

    Balance Sheet

    The company has 1.09M in cash and 12K in debt, giving a net cash position of 1.08M.

    Cash & Cash Equivalents

    n/a
    		 1.09M

    Total Debt

    n/a
    		 12K

    Net Cash

    n/a
    		 1.08M

    Retained Earnings

    n/a
    		 -171.7M

    Total Assets

    n/a
    		 3.48M

    Working Capital

    n/a
    		 1.38M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -11.04M and capital expenditures -5K, giving a free cash flow of -11.05M.

    Operating Cash Flow

    n/a
    		 -11.04M

    Capital Expenditures

    n/a
    		 -5K

    Free Cash Flow

    n/a
    		 -11.05M

    FCF Per Share

    n/a
    		 -4.08
    Full Cash Flow Statement

    Margins

    Gross margin is -11.92%, with operating and profit margins of -2673.65% and -2258.08%.

    Gross Margin

    n/a
    		 -11.92%

    Operating Margin

    n/a
    		 -2673.65%

    Pretax Margin

    n/a
    		 -2258.08%

    Profit Margin

    n/a
    		 -2258.08%

    EBITDA Margin

    n/a
    		 -2654.42%

    EBIT Margin

    n/a
    		 -2673.65%

    FCF Margin

    n/a
    		 -2124.23%

    Dividends & Yields

    HSDT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for HSDT is $24, which is 155.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $24

    Price Target Difference

    n/a
    		 155.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 1, 2025. It was a backward split with a ratio of 1:50.

    Last Split Date

    n/a
    		 Jul 1, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:50

    Scores

    Altman Z-Score

    n/a
    		 -66.66

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist